vs
Side-by-side financial comparison of BankUnited, Inc. (BKU) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
BankUnited, Inc. is the larger business by last-quarter revenue ($288.2M vs $207.8M, roughly 1.4× IDEAYA Biosciences, Inc.).
BankUnited, Inc. is the bank holding company of BankUnited, N.A., a national bank founded in 1984 and headquartered in Miami Lakes, Florida. The company operates in Florida; the regions in and around Atlanta, Georgia; Dallas, Texas; Morristown, New Jersey; Charlotte, North Carolina; and in the New York metropolitan area. BankUnited also offers certain commercial lending and deposit products through national platforms and has total assets of $35.0 billion as of December 31, 2025
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
BKU vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $288.2M | $207.8M |
| Net Profit | — | $119.2M |
| Gross Margin | — | — |
| Operating Margin | 31.2% | 52.2% |
| Net Margin | — | 57.4% |
| Revenue YoY | 9.0% | — |
| Net Profit YoY | — | 330.1% |
| EPS (diluted) | $0.89 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $288.2M | — | ||
| Q3 25 | $275.7M | $207.8M | ||
| Q2 25 | $273.9M | — | ||
| Q1 25 | $255.4M | — | ||
| Q4 24 | $264.5M | — | ||
| Q3 24 | $257.0M | $0 | ||
| Q2 24 | $250.2M | $0 | ||
| Q1 24 | $241.7M | $0 |
| Q4 25 | — | — | ||
| Q3 25 | $71.9M | $119.2M | ||
| Q2 25 | $68.8M | — | ||
| Q1 25 | $58.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $61.5M | $-51.8M | ||
| Q2 24 | $53.7M | $-52.8M | ||
| Q1 24 | $48.0M | $-39.6M |
| Q4 25 | 31.2% | — | ||
| Q3 25 | 35.5% | 52.2% | ||
| Q2 25 | 34.3% | — | ||
| Q1 25 | 31.4% | — | ||
| Q4 24 | 35.2% | — | ||
| Q3 24 | 32.4% | — | ||
| Q2 24 | 29.2% | — | ||
| Q1 24 | 27.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 26.1% | 57.4% | ||
| Q2 25 | 25.1% | — | ||
| Q1 25 | 22.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | 21.5% | — | ||
| Q1 24 | 19.8% | — |
| Q4 25 | $0.89 | — | ||
| Q3 25 | $0.95 | $1.33 | ||
| Q2 25 | $0.91 | — | ||
| Q1 25 | $0.78 | — | ||
| Q4 24 | $0.91 | — | ||
| Q3 24 | $0.81 | $-0.60 | ||
| Q2 24 | $0.72 | $-0.68 | ||
| Q1 24 | $0.64 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $217.8M | $786.9M |
| Total DebtLower is stronger | $319.7M | — |
| Stockholders' EquityBook value | $3.1B | $1.1B |
| Total Assets | $35.0B | $1.2B |
| Debt / EquityLower = less leverage | 0.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $217.8M | — | ||
| Q3 25 | $559.5M | $786.9M | ||
| Q2 25 | $801.3M | — | ||
| Q1 25 | $443.7M | — | ||
| Q4 24 | $491.1M | — | ||
| Q3 24 | $889.9M | $920.0M | ||
| Q2 24 | $433.5M | $701.7M | ||
| Q1 24 | $421.2M | $698.8M |
| Q4 25 | $319.7M | — | ||
| Q3 25 | $320.4M | — | ||
| Q2 25 | $708.9M | — | ||
| Q1 25 | $709.1M | — | ||
| Q4 24 | $708.6M | — | ||
| Q3 24 | $708.7M | — | ||
| Q2 24 | $708.8M | — | ||
| Q1 24 | $709.0M | — |
| Q4 25 | $3.1B | — | ||
| Q3 25 | $3.0B | $1.1B | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $2.9B | — | ||
| Q4 24 | $2.8B | — | ||
| Q3 24 | $2.8B | $1.2B | ||
| Q2 24 | $2.7B | $931.7M | ||
| Q1 24 | $2.6B | $935.3M |
| Q4 25 | $35.0B | — | ||
| Q3 25 | $35.1B | $1.2B | ||
| Q2 25 | $35.5B | — | ||
| Q1 25 | $34.8B | — | ||
| Q4 24 | $35.2B | — | ||
| Q3 24 | $35.8B | $1.2B | ||
| Q2 24 | $35.4B | $973.7M | ||
| Q1 24 | $35.1B | $961.5M |
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.11× | — | ||
| Q2 25 | 0.24× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.25× | — | ||
| Q3 24 | 0.25× | — | ||
| Q2 24 | 0.26× | — | ||
| Q1 24 | 0.27× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $358.6M | $142.2M |
| Free Cash FlowOCF − Capex | — | $142.2M |
| FCF MarginFCF / Revenue | — | 68.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $358.6M | — | ||
| Q3 25 | $99.7M | $142.2M | ||
| Q2 25 | $117.6M | — | ||
| Q1 25 | $16.4M | — | ||
| Q4 24 | $433.8M | — | ||
| Q3 24 | $46.1M | $-49.2M | ||
| Q2 24 | $135.7M | $-32.9M | ||
| Q1 24 | $66.5M | $-43.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $142.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-49.7M | ||
| Q2 24 | — | $-33.9M | ||
| Q1 24 | — | $-45.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | 68.4% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.39× | 1.19× | ||
| Q2 25 | 1.71× | — | ||
| Q1 25 | 0.28× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.75× | — | ||
| Q2 24 | 2.53× | — | ||
| Q1 24 | 1.39× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
